As CREB is overexpressed and constitutively phosphorylated in a number of human cancers, promoting survival and proliferation via different pathways (29), p32-T130M expression potentially triggers tumor-inhibiting signaling pathways as a result of decreased CREB activation. This evidence concerns the gene CREB1 and neoplasm.